Author: Zacks Small Cap Research

123413620 / 1351 POSTS
By David Bautz, PhD NASDAQ:BTAI READ THE FULL BTAI RESEARCH REPORT Business Update Encouraging Data for BXCL701 in Heavily Pretreated mCRPC Population On September 15, 2021, BioXcel Therapeutics, Inc. (BTAI) announced that data from the ongoing Phase ...
By T. Moore, CFA NASDAQ:YTRA READ THE FULL YTRA RESEARCH REPORT Business News Update We were pleasantly surprised by the news that Yatra Online, Inc. (NASDAQ:YTRA) is considering whether to do additional listing of its Indian subsidiary on stock exch ...
By John Vandermosten, CFA NASDAQ:ALZN | NASDAQ:BIIB Alzamend Neuro, Inc. (NASDAQ:ALZN) is an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative and psychiatric disorders. The Tam ...
By Steven Ralston, CFA OTC:BLSTF | ASX:BSX READ THE FULL BLSTF RESEARCH REPORT Blackstone Minerals (OTC:BLSTF) (ASX:BSX) is advancing both upstream and downstream nickel projects in northern Vietnam. The upstream Ta Khoa Project is developing a serie ...
By John Vandermosten, CFA EPA:ALQGC READ THE FULL ALQGC RESEARCH REPORT QUORUM Study Results Announcement Quantum Genomics S.A. (EPA:ALQGC) reported topline results for the QUORUM study which were presented at the European Society of Cardiology (ESC ...
By John Vandermosten, CFA NASDAQ:HTBX READ THE FULL HTBX RESEARCH REPORT Business Update Conference Call Heat Biologics, Inc. (NASDAQ:HTBX) hosted a business update conference call on September 2, 2021 to discuss the status of active programs, objec ...
By David Bautz, PhD NASDAQ:BTAI READ THE FULL BTAI RESEARCH REPORT Business Update PDUFA Date for BXCL501 of January 5, 2022; MAA Submission Expected 2H21 In May 2021, BioXcel Therapeutics, Inc. (NASDAQ:BTAI) announced that the New Drug Application ( ...
By Lisa Thompson NYSE:DSS READ THE FULL DSS RESEARCH REPORT Document Security Systems (NYSE:DSS) has evolved into a multi-industry business growing through opportunistic acquisitions. Its roots lie in packaging and document printing. It has a new dir ...
By John Vandermosten, CFA NASDAQ:TLSA | LSE:TILS READ THE FULL TLSA RESEARCH REPORT On September 2nd, Tiziana Life Sciences PLC (NASDAQ:TLSA) (LSE:TILS) announced an exclusive licensing agreement with Precision BioSciences (NASDAQ:DTIL) for the explo ...
By David Bautz, PhD NASDAQ:EDSA READ THE FULL EDSA RESEARCH REPORT Business Update Nearing End of Phase 2 Analysis for EB05 Phase 2/3 Trial in COVID-19 Edesa Biotech, Inc. (NASDAQ:EDSA) is currently conducting a Phase 2/3 clinical trial of EB05 in pa ...
123413620 / 1351 POSTS